Top compounds associated with response to CPVL


Feature Type Standardized
Nominal ANOVA
mRNA ML210 CTRPv2 pan-cancer AAC 0.065 0.05
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.063 0.05
mRNA JW-7-24-1 GDSC1000 pan-cancer AAC 0.059 0.05
mRNA blebbistatin CTRPv2 pan-cancer AAC 0.14 0.05
mRNA CCT007093 GDSC1000 pan-cancer AAC 0.068 0.05
mRNA BRD-K24690302 CTRPv2 pan-cancer AAC 0.07 0.06
mRNA paclitaxel CCLE pan-cancer AAC -0.085 0.06
mRNA Mitomycin-C GDSC1000 pan-cancer AAC 0.068 0.06
mRNA GSK4112 CTRPv2 pan-cancer AAC 0.069 0.06
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.068 0.06
Download CSV